Approval · Notice of Compliance 10385 · 2009
RIDAURA: Notice of Compliance 10385
Issued July 15, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10385
- Date
- July 15, 2009
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antirheumatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RIDAURA | 01916823 | Marketed |
Medicinal ingredients
- AURANOFIN 3 MG per CAP